Synthesis, characterization, cytotoxic activity, and molecular docking of 3,4-diaminobenzophenone-CuhNFs and its major components-based nanoflowers
Özet
In this study, organic–inorganic hybrid nanoflower (hNFs) synthesis was realized using 3,4-diaminobenzophenone and Cu(II) metal ions as organic and inorganic ingredients, respectively. The characterization of the synthesized hNFs was carried out using SEM, EDX, FT-IR, XRD, and elemental mapping. The cytotoxic effect of hNFs was investigated against A549 (lung) and MCF-7 (breast) cancer cell lines. Interactions of 3,4-diaminobenzophenone were also investigated via molecular docking studies at the binding site of the human estrogen receptor (PDB ID:3ERT) and epidermal growth factor receptor tyrosine kinase (PDB ID: 1M17). Physicochemical and pharmacokinetic parameters for ligands that could be potential anticancer drug candidates were determined by ADME prediction calculations from in silico approaches. In vitro results showed an increase in cell death when the synthesized hybrid nanoflowers were applied against both cell lines, depending on the concentrations tested. Additionally, it was determined that the synthesized nanoflower was more effective on the MCF-7 cell line. © 2024 Informa UK Limited, trading as Taylor & Francis Group.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Somturk-Yilmaz, Burcu | |
| dc.contributor.author | Altiparmak, Ayşegül | |
| dc.contributor.author | Turkmenoglu, Burçin | |
| dc.contributor.author | Akkoc, Senem | |
| dc.date.accessioned | 2026-10-18T20:26:21.589537970Z | |
| dc.date.available | 2026-10-18T20:26:21.589537970Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | In this study, organic–inorganic hybrid nanoflower (hNFs) synthesis was realized using 3,4-diaminobenzophenone and Cu(II) metal ions as organic and inorganic ingredients, respectively. The characterization of the synthesized hNFs was carried out using SEM, EDX, FT-IR, XRD, and elemental mapping. The cytotoxic effect of hNFs was investigated against A549 (lung) and MCF-7 (breast) cancer cell lines. Interactions of 3,4-diaminobenzophenone were also investigated via molecular docking studies at the binding site of the human estrogen receptor (PDB ID:3ERT) and epidermal growth factor receptor tyrosine kinase (PDB ID: 1M17). Physicochemical and pharmacokinetic parameters for ligands that could be potential anticancer drug candidates were determined by ADME prediction calculations from in silico approaches. In vitro results showed an increase in cell death when the synthesized hybrid nanoflowers were applied against both cell lines, depending on the concentrations tested. Additionally, it was determined that the synthesized nanoflower was more effective on the MCF-7 cell line. © 2024 Informa UK Limited, trading as Taylor & Francis Group. | |
| dc.description.sponsorship | Funding text 1: The authors would like to thank Erzincan Binali Y\u0131ld\u0131r\u0131m University, Basic Sciences Application and Research Center (EBYU-EUTAM) for the Schr\u00F6dinger Maestro 2021-2 program. SA thanks the Suleyman Demirel University Research Fund (TSG-2021-8458) for partial financial support. BSY would like to thank the Erciyes University Drug Application and Research Center (ERFARMA) for laboratory and device support. SA would like to thank the Suleyman Demirel University Research Fund (TSG-2024-9516) for their financial support.; Funding text 2: BSY would like to thank the Erciyes University Drug Application and Research Center (ERFARMA) for laboratory and device support. SA would like to thank the Suleyman Demirel University Research Fund (TSG-2024-9516) for their financial support. | |
| dc.identifier.doi | 10.1080/07391102.2024.2435626 | |
| dc.identifier.eissn | 1538-0254 | |
| dc.identifier.endpage | 8616 | |
| dc.identifier.issn | 0739-1102 | |
| dc.identifier.issue | 15 | |
| dc.identifier.pmid | 39616550 | |
| dc.identifier.scopus | 2-s2.0-85210740328 | |
| dc.identifier.startpage | 8606 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/11285 | |
| dc.identifier.volume | 43 | |
| dc.identifier.wos | WOS:001367384300001 | |
| dc.language.iso | en | |
| dc.publisher | Taylor and Francis Ltd. | |
| dc.relation.ispartof | Journal of Biomolecular Structure and Dynamics | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | copper | |
| dc.subject | Cytotoxic activity | |
| dc.subject | molecular docking | |
| dc.subject | nanoflowers | |
| dc.subject | A549 Cells | |
| dc.subject | Antineoplastic Agents | |
| dc.subject | Binding Sites | |
| dc.subject | Cell Line, Tumor | |
| dc.subject | Cell Proliferation | |
| dc.subject | Cell Survival | |
| dc.subject | ErbB Receptors | |
| dc.subject | Humans | |
| dc.subject | Ligands | |
| dc.subject | MCF-7 Cells | |
| dc.subject | Molecular Docking Simulation | |
| dc.subject | Nanostructures | |
| dc.subject | 3,4 diaminobenzophenone | |
| dc.subject | chemical compound | |
| dc.subject | epidermal growth factor receptor | |
| dc.subject | estrogen receptor | |
| dc.subject | nanoflower | |
| dc.subject | unclassified drug | |
| dc.subject | antineoplastic agent | |
| dc.subject | ligand | |
| dc.subject | nanomaterial | |
| dc.subject | A-549 cell line | |
| dc.subject | antineoplastic activity | |
| dc.subject | Article | |
| dc.subject | cell culture | |
| dc.subject | chemical structure | |
| dc.title | Synthesis, characterization, cytotoxic activity, and molecular docking of 3,4-diaminobenzophenone-CuhNFs and its major components-based nanoflowers | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 1 | |
| rdl.citation.wos | 1 | |
| rdl.department | Faculty of Pharmacy, Department of Analytical Chemistry, Erzincan Binali Yıldırım University, Erzincan, Türkiye. | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
